» Articles » PMID: 32612568

Anti-Dopamine Receptor 2 Antibody-Positive Encephalitis in Adolescent

Overview
Journal Front Neurol
Specialty Neurology
Date 2020 Jul 3
PMID 32612568
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Autoimmune encephalitic syndromes include mutism, somnolence, movement disorder, and behavioral, or psychiatric symptoms. When paired with bilateral basal ganglia lesions on magnetic resonance imaging, these support the diagnosis of basal ganglia encephalitis (BGE). BGE is a rare but distinct entity of putative autoimmune etiology, with specific basal ganglia inflammation and acute movement disorders. A previous study identified dopamine-2 receptors (D2R) antibody to be positive in most BGE children, indicating that the D2R antibody may trigger the downstream pathological process in BGE patients. The highest levels of D2R are found in the striatum, the nucleus accumbens, and the olfactory tubercle. D2R antibody-positive BGE is widely reported in children. Here we present a 17-year-old girl with a typical clinical feature of basal ganglia encephalitis, who benefited from immune therapy.

Citing Articles

Decoding Dystonia in Autoimmune Disorders: A Scoping Review.

Dutta D, Yadav R Tremor Other Hyperkinet Mov (N Y). 2024; 14:60.

PMID: 39651491 PMC: 11623079. DOI: 10.5334/tohm.915.


Anti-dopamine receptor 2 antibody encephalitis in adults: a case report.

Wu X, Shi M, Zhang H BMC Neurol. 2024; 24(1):398.

PMID: 39425067 PMC: 11488131. DOI: 10.1186/s12883-024-03893-9.


An Autopsy-proven Case-based Review of Autoimmune Encephalitis.

Shim Y, Kim S, Lim S, Lee K, Kim E, Won J Exp Neurobiol. 2024; 33(1):1-17.

PMID: 38471800 PMC: 10938074. DOI: 10.5607/en23036.


Autoimmune Encephalitis and Other Neurological Syndromes With Rare Neuronal Surface Antibodies in Children: A Systematic Literature Review.

Ancona C, Masenello V, Tinnirello M, Toscano L, Leo A, La Piana C Front Pediatr. 2022; 10:866074.

PMID: 35515348 PMC: 9067304. DOI: 10.3389/fped.2022.866074.

References
1.
Kebabian J, Calne D . Multiple receptors for dopamine. Nature. 1979; 277(5692):93-6. DOI: 10.1038/277093a0. View

2.
Pawela C, Brunsdon R, Williams T, Porter M, Dale R, Mohammad S . The neuropsychological profile of children with basal ganglia encephalitis: a case series. Dev Med Child Neurol. 2016; 59(4):445-448. DOI: 10.1111/dmcn.13351. View

3.
Seeman P . Targeting the dopamine D2 receptor in schizophrenia. Expert Opin Ther Targets. 2006; 10(4):515-31. DOI: 10.1517/14728222.10.4.515. View

4.
Beaulieu J, Gainetdinov R . The physiology, signaling, and pharmacology of dopamine receptors. Pharmacol Rev. 2011; 63(1):182-217. DOI: 10.1124/pr.110.002642. View

5.
Gerfen C . Molecular effects of dopamine on striatal-projection pathways. Trends Neurosci. 2000; 23(10 Suppl):S64-70. DOI: 10.1016/s1471-1931(00)00019-7. View